Description

Mirabegron 25 mg is a prescription medication that offers relief to individuals suffering from Overactive Bladder (OAB)—a condition characterized by sudden, involuntary contractions of the bladder muscle that lead to frequent urges to urinate, urgency, and sometimes urinary incontinence. With its innovative mechanism of action, Mirabegron represents a breakthrough alternative to traditional anticholinergic drugs, offering both efficacy and improved tolerability. What is Mirabegron 25 mg? Mirabegron is a beta-3 adrenergic receptor agonist used to treat Overactive Bladder symptoms. The 25 mg dose is typically prescribed as a starting dose, which may be increased depending on individual response and tolerance. Unlike conventional anticholinergic drugs, Mirabegron does not inhibit acetylcholine, reducing the risk of side effects such as dry mouth, constipation, and blurred vision. It is a well-tolerated, once-daily oral treatment that provides sustained relief from OAB symptoms. Uses of Mirabegron 25 mg Mirabegron 25 mg is prescribed for the treatment of: Overactive Bladder (OAB) Frequent urination (eight or more times in 24 hours) Urgency (sudden, strong need to urinate) Urge urinary incontinence (leakage associated with urgency) Neurogenic Detrusor Overactivity (NDO) (in some regions) Especially in patients with neurological conditions like spinal cord injury or multiple sclerosis. Combination Therapy Sometimes prescribed along with anticholinergics for better symptom control in patients who don’t respond adequately to monotherapy. How Does Mirabegron 25 mg Work? Mirabegron works by activating beta-3 adrenergic receptors in the bladder’s detrusor muscle. This leads to relaxation of the bladder wall, allowing it to store more urine, reducing the frequency and urgency of urination. Unlike anticholinergics, which block nerve signals, Mirabegron works by enhancing the bladder’s ability to hold urine, making it a first-in-class beta-3 agonist for OAB treatment. Mirabegron 25 mg Dosage and Administration Recommended starting dose: 25 mg once daily, taken with or without food. Dose escalation: May be increased to 50 mg once daily based on clinical response. Renal or hepatic impairment: Dose adjustments may be required in patients with moderate kidney or liver dysfunction. Note: Do not crush, split, or chew the tablet. It should be swallowed whole. Benefits of Mirabegron 25 mg Reduces urinary frequency and urgency Lowers the risk of urge incontinence Minimal anticholinergic side effects Improved patient compliance Once-daily convenient dosing Suitable for long-term use Better quality of life and confidence Mirabegron has shown statistically significant improvement in both objective (number of urinations) and subjective (quality of life) measures in clinical trials. Side Effects of Mirabegron 25 mg Like all medications, Mirabegron can cause side effects, although not everyone experiences them. Common side effects include: Increased blood pressure Nasopharyngitis (cold-like symptoms) Urinary tract infection (UTI) Headache Constipation Dizziness Serious but rare side effects may include: Elevated heart rate (tachycardia) Severe hypertension Angioedema (swelling of the face, lips, or throat) If you experience symptoms like difficulty breathing or severe allergic reactions, seek immediate medical help. Precautions Before Taking Mirabegron 25 mg Before starting treatment, inform your doctor if you have: Uncontrolled high blood pressure Kidney or liver disease History of urinary retention Heart rhythm disorders Pregnancy or are breastfeeding Mirabegron should be used with caution in elderly patients, especially those on multiple medications.